DermEdge Research Inc. | Mississauga, Canada
Status and phase
Conditions
Treatments
Study type
Funder types
Identifiers
About
The main purpose of this study is to measure the effect, safety and how well the body absorbs lebrikizumab in pediatric participants 6 months to <18 years of age with moderate-to-severe atopic dermatitis (AD).
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Academy of Dermatology for at least:
12 months s if participants are ≥6 years of age, and
6 months if participants are 6 months to <6 years of age
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
300 participants in 3 patient groups, including a placebo group
Loading...
Central trial contact
There may be multiple sites in this clinical trial. 1-877-CTLILLY (1-877-285-4559)
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal